414 related articles for article (PubMed ID: 27281570)
1. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
Henry Dunand CJ; Leon PE; Huang M; Choi A; Chromikova V; Ho IY; Tan GS; Cruz J; Hirsh A; Zheng NY; Mullarkey CE; Ennis FA; Terajima M; Treanor JJ; Topham DJ; Subbarao K; Palese P; Krammer F; Wilson PC
Cell Host Microbe; 2016 Jun; 19(6):800-13. PubMed ID: 27281570
[TBL] [Abstract][Full Text] [Related]
2. Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection.
Tan GS; Leon PE; Albrecht RA; Margine I; Hirsh A; Bahl J; Krammer F
PLoS Pathog; 2016 Apr; 12(4):e1005578. PubMed ID: 27081859
[TBL] [Abstract][Full Text] [Related]
3. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
[TBL] [Abstract][Full Text] [Related]
4. A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site A from fifth wave H7N9-infected humans.
Li M; Chen L; Wang Q; Hao M; Zhang X; Liu L; Yu X; Yang C; Xu J; Chen J; Gong R
Antiviral Res; 2019 Oct; 170():104556. PubMed ID: 31299269
[TBL] [Abstract][Full Text] [Related]
5. An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.
Krammer F; Jul-Larsen A; Margine I; Hirsh A; Sjursen H; Zambon M; Cox RJ
Clin Vaccine Immunol; 2014 Aug; 21(8):1153-63. PubMed ID: 24943383
[TBL] [Abstract][Full Text] [Related]
6. Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head.
Jia M; Zhao H; Morano NC; Lu H; Lui YM; Du H; Becker JE; Yuen KY; Ho DD; Kwong PD; Shapiro L; To KK; Wu X
Nat Commun; 2024 May; 15(1):4505. PubMed ID: 38802413
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.
Stadlbauer D; Amanat F; Strohmeier S; Nachbagauer R; Krammer F
Emerg Microbes Infect; 2018 Jun; 7(1):110. PubMed ID: 29925896
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
Schmeisser F; Vasudevan A; Verma S; Wang W; Alvarado E; Weiss C; Atukorale V; Meseda C; Weir JP
PLoS One; 2015; 10(1):e0117108. PubMed ID: 25629172
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model.
Roubidoux EK; Carreño JM; McMahon M; Jiang K; van Bakel H; Wilson P; Krammer F
mBio; 2021 Feb; 12(1):. PubMed ID: 33593972
[TBL] [Abstract][Full Text] [Related]
11. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
[TBL] [Abstract][Full Text] [Related]
12. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
13. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
[TBL] [Abstract][Full Text] [Related]
14. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
15. A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin.
Yu F; Song H; Wu Y; Chang SY; Wang L; Li W; Hong B; Xia S; Wang C; Khurana S; Feng Y; Wang Y; Sun Z; He B; Hou D; Manischewitz J; King LR; Song Y; Min JY; Golding H; Ji X; Lu L; Jiang S; Dimitrov DS; Ying T
Cell Host Microbe; 2017 Oct; 22(4):471-483.e5. PubMed ID: 28966056
[TBL] [Abstract][Full Text] [Related]
16. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
Henry Dunand CJ; Leon PE; Kaur K; Tan GS; Zheng NY; Andrews S; Huang M; Qu X; Huang Y; Salgado-Ferrer M; Ho IY; Taylor W; Hai R; Wrammert J; Ahmed R; García-Sastre A; Palese P; Krammer F; Wilson PC
J Clin Invest; 2015 Mar; 125(3):1255-68. PubMed ID: 25689254
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.
Henry C; Palm AE; Utset HA; Huang M; Ho IY; Zheng NY; Fitzgerald T; Neu KE; Chen YQ; Krammer F; Treanor JJ; Sant AJ; Topham DJ; Wilson PC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31434733
[TBL] [Abstract][Full Text] [Related]
19. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
Meseda CA; Atukorale V; Soto J; Eichelberger MC; Gao J; Wang W; Weiss CD; Weir JP
Sci Rep; 2018 Mar; 8(1):5364. PubMed ID: 29599502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
